From latency to overt bone metastasis in breast cancer: potential for treatment and prevention.

Animals Bone Neoplasms / metabolism Breast Neoplasms / metabolism Cell Proliferation Cell Survival Disease Progression Female Humans Neoplasm Micrometastasis Neoplastic Cells, Circulating / metabolism Prognosis Time Factors Tumor Microenvironment
biomarker bisphosphonates bone breast cancer dormancy latency metastasis

Journal

The Journal of pathology
ISSN: 1096-9896
Titre abrégé: J Pathol
Pays: England
ID NLM: 0204634

Informations de publication

Date de publication:
09 2019
Historique:
received: 25 03 2019
revised: 03 05 2019
accepted: 13 05 2019
pubmed: 17 5 2019
medline: 14 4 2020
entrez: 17 5 2019
Statut: ppublish

Résumé

Bone metastasis is present in a high percentage of breast cancer (BCa) patients with distant disease, especially in those with the estrogen receptor-positive (ER

Identifiants

DOI: 10.1002/path.5292 PMID: 31095738 PMC: PMC6771808
pubmed: 31095738
doi: 10.1002/path.5292
pmc: PMC6771808
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

6-18

Informations de copyright

© 2019 The Authors. The Journal of Pathology published by John Wiley & Sons Ltd on behalf of Pathological Society of Great Britain and Ireland.

Références

Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14793-14798
pubmed: 27930335
Tohoku J Exp Med. 2011;225(2):95-101
pubmed: 21908955
Nature. 2007 Oct 11;449(7163):682-8
pubmed: 17898713
Sci Transl Med. 2018 Aug 1;10(452):
pubmed: 30068572
Cell. 2012 Aug 17;150(4):764-79
pubmed: 22901808
J Exp Med. 2011 Dec 19;208(13):2641-55
pubmed: 22124112
J Clin Oncol. 2017 Jun 20;35(18):2062-2081
pubmed: 28618241
Int J Oncol. 2004 May;24(5):1235-44
pubmed: 15067347
Nat Rev Cancer. 2007 Nov;7(11):834-46
pubmed: 17957189
J Natl Cancer Inst. 2015 Sep 15;107(12):djv256
pubmed: 26376684
J Mammary Gland Biol Neoplasia. 2005 Apr;10(2):169-80
pubmed: 16025223
Nature. 2006 Mar 30;440(7084):692-6
pubmed: 16572175
Cell. 1997 Apr 18;89(2):309-19
pubmed: 9108485
Trends Cancer. 2015 Sep;1(1):76-91
pubmed: 28741564
Nat Med. 2012 Aug;18(8):1224-31
pubmed: 22820642
Sci Transl Med. 2017 Jan 25;9(374):
pubmed: 28123075
N Engl J Med. 2012 Jun 28;366(26):2455-65
pubmed: 22658128
Oncogene. 2019 Feb;38(6):808-821
pubmed: 30177834
Breast Cancer Res Treat. 2010 Oct;123(3):767-79
pubmed: 20574672
Cancer Res. 2016 Oct 1;76(19):5857-5869
pubmed: 27480274
J Clin Invest. 2003 Apr;111(8):1221-30
pubmed: 12697741
Cell. 2016 Mar 24;165(1):45-60
pubmed: 27015306
Cancer Treat Rev. 2008 Nov;34(7):629-39
pubmed: 18579314
J Cell Physiol. 1998 Sep;176(3):482-94
pubmed: 9699501
Sci Rep. 2018 Jan 8;8(1):39
pubmed: 29311633
Clin Oncol (R Coll Radiol). 2013 Apr;25(4):217-26
pubmed: 23219232
J Pathol. 2019 Mar;247(3):381-391
pubmed: 30426503
Nature. 2016 Jan 21;529(7586):298-306
pubmed: 26791720
Cancer Cell. 2011 Feb 15;19(2):192-205
pubmed: 21295524
Nat Cell Biol. 2016 Sep 19;18(10):1078-1089
pubmed: 27642788
Blood. 2001 Jan 15;97(2):346-51
pubmed: 11154207
Nat Rev Clin Oncol. 2011 Dec 20;9(2):76-8
pubmed: 22182971
Mod Pathol. 2018 Jan;31(1):56-61
pubmed: 28799536
PLoS One. 2013 May 07;8(5):e62936
pubmed: 23667544
Breast Cancer Res. 2018 Oct 22;20(1):127
pubmed: 30348200
J Clin Oncol. 2006 Aug 10;24(23):3726-34
pubmed: 16720680
Clin Cancer Res. 2009 Dec 15;15(24):7479-7491
pubmed: 20008848
J Bone Miner Res. 2001 Aug;16(8):1388-98
pubmed: 11499861
Nature. 2014 Mar 27;507(7493):508-12
pubmed: 24553136
J Clin Oncol. 2005 Aug 1;23(22):4925-35
pubmed: 15983391
Endocr Rev. 2008 Apr;29(2):155-92
pubmed: 18057140
Nature. 2010 Apr 15;464(7291):999-1005
pubmed: 20393555
JBMR Plus. 2018 Jun 22;2(6):362-366
pubmed: 30460339
Transl Oncol. 2019 Mar;12(3):462-474
pubmed: 30583289
J Clin Invest. 1999 Jan;103(2):197-206
pubmed: 9916131
Cancer Cell. 2017 Dec 11;32(6):731-747.e6
pubmed: 29232552
J Cell Physiol. 2010 Jan;222(1):42-9
pubmed: 19798694
N Engl J Med. 2016 Aug 25;375(8):717-29
pubmed: 27557300
Nat Med. 2007 Jul;13(7):791-801
pubmed: 17618270
Oncotarget. 2017 Jan 31;8(5):8406-8419
pubmed: 28039445
Nat Cell Biol. 2013 Nov;15(11):1351-61
pubmed: 24161934
Bone. 2013 Jun;54(2):258-63
pubmed: 22939943
Nature. 2018 Jan 25;553(7689):467-472
pubmed: 29342134
Lancet Oncol. 2017 Nov;18(11):1543-1552
pubmed: 29037984
Diagn Mol Pathol. 1996 Jun;5(2):127-35
pubmed: 8727100
Cancer Res. 2017 May 1;77(9):2213-2221
pubmed: 28249905
N Engl J Med. 2004 Mar 11;350(11):1081-92
pubmed: 15014181
Nat Rev Clin Oncol. 2018 May;15(5):268-270
pubmed: 29459643
Nat Rev Mol Cell Biol. 2011 Dec 22;13(1):27-38
pubmed: 22189423
Cell. 2007 Sep 7;130(5):811-23
pubmed: 17803905
Proc Natl Acad Sci U S A. 2018 Jan 30;115(5):E992-E1001
pubmed: 29339479
J Clin Invest. 2006 Mar;116(3):561-70
pubmed: 16511588
J Bone Oncol. 2018 Nov 06;15:004-4
pubmed: 30937279
Annu Rev Med. 2011;62:233-47
pubmed: 20887199
Nat Rev Cancer. 2005 Aug;5(8):591-602
pubmed: 16056258
Mol Oncol. 2016 Oct 7;11(1):62-78
pubmed: 28017284
J Natl Cancer Inst. 2016 Jan 12;108(4):
pubmed: 26757732
Breast Cancer Res Treat. 2010 Apr;120(3):753-9
pubmed: 19701704
Mol Cancer. 2018 Jan 17;17(1):9
pubmed: 29343249
Neoplasia. 2012 Aug;14(8):709-18
pubmed: 22952424
Nat Rev Drug Discov. 2012 Jun 01;11(6):479-97
pubmed: 22653217
Clin Cancer Res. 2011 Apr 1;17(7):2055-64
pubmed: 21307144
J Clin Oncol. 2016 Apr 1;34(10):1134-50
pubmed: 26858339
J Pathol. 2012 Jun;227(2):234-44
pubmed: 22262199
Cancer. 2008 Jul 1;113(1):193-201
pubmed: 18459173
Nat Cell Biol. 2018 Feb;20(2):211-221
pubmed: 29358704
Nat Rev Clin Oncol. 2011 Dec 06;9(1):48-57
pubmed: 22143140
J Clin Oncol. 2010 Jul 10;28(20):3271-7
pubmed: 20498394
Curr Opin Support Palliat Care. 2012 Sep;6(3):322-9
pubmed: 22801464
Clin Cancer Res. 2016 May 15;22(10):2583-93
pubmed: 26733614
Med Clin (Barc). 2010 Jun 12;135(2):70-4
pubmed: 20022069
Nat Rev Cancer. 2009 Apr;9(4):274-84
pubmed: 19308067
J Bone Miner Res. 1994 Apr;9(4):487-96
pubmed: 7518179
Int J Cancer. 2001 Apr 1;92(1):96-105
pubmed: 11279612
J Biol Chem. 2003 Dec 5;278(49):48684-9
pubmed: 14506237
J Biol Chem. 2012 Dec 7;287(50):42084-92
pubmed: 23060446
Endocrinology. 1998 Mar;139(3):1329-37
pubmed: 9492069
Oncotarget. 2016 Nov 15;7(46):75571-75584
pubmed: 27765923
Cancer Cell. 2011 Dec 13;20(6):701-14
pubmed: 22137794
Proc Natl Acad Sci U S A. 2003 Sep 16;100(19):10954-9
pubmed: 12941866
Breast Care (Basel). 2013 May;8(2):149-54
pubmed: 24415964
J Endocrinol. 2001 Nov;171(2):229-36
pubmed: 11691642
Clin Breast Cancer. 2010 Dec 1;10(6):452-8
pubmed: 21147688
Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10519-24
pubmed: 18650380
Lancet Oncol. 2014 Aug;15(9):997-1006
pubmed: 25035292
Cancer Cell. 2003 Jun;3(6):537-49
pubmed: 12842083
Lancet. 2015 Oct 3;386(10001):1353-1361
pubmed: 26211824
Nat Cell Biol. 2008 Feb;10(2):202-10
pubmed: 18193036
J Bone Miner Res. 1996 May;11(5):665-70
pubmed: 9157781
Cancer Cell. 2015 Feb 9;27(2):193-210
pubmed: 25600338
Cancer Lett. 2007 Sep 18;255(1):57-70
pubmed: 17493746
Nature. 2008 Jan 10;451(7175):147-52
pubmed: 18185580
J Proteome Res. 2013 Aug 2;12(8):3780-91
pubmed: 23782053
Nature. 2010 Nov 4;468(7320):103-7
pubmed: 20881963
Nat Rev Cancer. 2011 Jun;11(6):411-25
pubmed: 21593787
Cell. 2015 Jan 15;160(1-2):17-9
pubmed: 25594172
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):13909-14
pubmed: 16172383
Ann Oncol. 2016 Mar;27(3):379-90
pubmed: 26681681
N Engl J Med. 2001 Mar 15;344(11):783-92
pubmed: 11248153
Cold Spring Harb Perspect Med. 2018 Jun 1;8(6):
pubmed: 29101110
Cancer Metastasis Rev. 2016 Dec;35(4):601-629
pubmed: 27858305
Genetika. 2005 Sep;41(9):1289-93
pubmed: 16240642
J Bone Oncol. 2018 Sep 27;13:123-135
pubmed: 30591866
Nat Cell Biol. 2013 Jul;15(7):807-17
pubmed: 23728425
Cancer Lett. 2015 Jun 1;361(2):262-70
pubmed: 25779674
Acta Oncol. 2012 Feb;51(2):157-67
pubmed: 22150116
Nat Rev Cancer. 2014 Sep;14(9):611-22
pubmed: 25118602
N Engl J Med. 2009 Feb 19;360(8):790-800
pubmed: 19228622
Nature. 2001 Mar 1;410(6824):50-6
pubmed: 11242036
Cell Res. 2016 Jul;26(7):761-74
pubmed: 27241552
Clin Transl Oncol. 2006 Jan;8(1):7-14
pubmed: 16632434
J Natl Cancer Inst. 2014 Apr 28;106(5):
pubmed: 24777111
J Natl Cancer Inst. 2018 Aug 1;110(8):871-879
pubmed: 29425304
Endocr Relat Cancer. 2014 Mar 07;21(2):327-41
pubmed: 24413608
Cell. 2006 Nov 17;127(4):679-95
pubmed: 17110329
Endocr Rev. 1999 Jun;20(3):345-57
pubmed: 10368775
Clin Cancer Res. 2016 Dec 1;22(23):5713-5721
pubmed: 27140926
J Natl Cancer Inst. 2015 Nov 19;108(3):
pubmed: 26586670
Nat Rev Drug Discov. 2012 May;11(5):401-19
pubmed: 22543469
Trends Endocrinol Metab. 2015 Sep;26(9):467-76
pubmed: 26183887
N Engl J Med. 2017 Oct 12;377(15):1417-1427
pubmed: 28892457

Auteurs

Fernando Salvador (F)

Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Alicia Llorente (A)

Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.

Roger R Gomis (RR)

Cancer Science Program, Institute for Research in Biomedicine (IRB Barcelona), The Barcelona Institute of Science and Technology, Barcelona, Spain.
CIBERONC, Barcelona, Spain.
ICREA, Institució Catalana de Recerca i Estudis Avançats, Barcelona, Spain.
School of Medicine, Universitat de Barcelona, Barcelona, Spain.
ORCID: 0000-0001-6473-2858

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › From latency to overt bone metastasis in...
questionsmedicales.fr › Maladies ostéomusculaires › Maladies osseuses › Tumeurs osseuses › From latency to overt bone metastasis in...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › From latency to overt bone metastasis in...
questionsmedicales.fr › Phénomènes physiologiques › Croissance et développement › Croissance › Processus de croissance cellulaire › Prolifération cellulaire › From latency to overt bone metastasis in...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Survie cellulaire › From latency to overt bone metastasis in...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Évolution de la maladie › From latency to overt bone metastasis in...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › From latency to overt bone metastasis in...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Métastase tumorale › Micrométastase tumorale › From latency to overt bone metastasis in...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Métastase tumorale › Cellules tumorales circulantes › From latency to overt bone metastasis in...
questionsmedicales.fr › Diagnostic › Pronostic › From latency to overt bone metastasis in...
questionsmedicales.fr › Phénomènes physiques › Temps › Facteurs temps › From latency to overt bone metastasis in...
questionsmedicales.fr › Phénomènes physiologiques cellulaires › Microenvironnement cellulaire › Microenvironnement tumoral › From latency to overt bone metastasis in...